168 related articles for article (PubMed ID: 17652162)
1. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
2. Increased bone resorption and osteopenia in Dlx5 heterozygous mice.
Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Clément-Lacroix P; Belleville C; Levi G; de Vernejoul MC
J Cell Biochem; 2009 Aug; 107(5):865-72. PubMed ID: 19415689
[TBL] [Abstract][Full Text] [Related]
3. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
4. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
5. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
[TBL] [Abstract][Full Text] [Related]
6. Deletion of membrane-bound steel factor results in osteopenia in mice.
Lotinun S; Evans GL; Turner RT; Oursler MJ
J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase in the control of osteoblastic mineralizing activity and bone integrity.
Afzal F; Polak J; Buttery L
J Pathol; 2004 Apr; 202(4):503-10. PubMed ID: 15095278
[TBL] [Abstract][Full Text] [Related]
10. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
Ali MM; Yoshizawa T; Ishibashi O; Matsuda A; Ikegame M; Shimomura J; Mera H; Nakashima K; Kawashima H
J Cell Sci; 2007 Aug; 120(Pt 15):2565-73. PubMed ID: 17623776
[TBL] [Abstract][Full Text] [Related]
11. Aged mice require full transcription factor, Runx2/Cbfa1, gene dosage for cancellous bone regeneration after bone marrow ablation.
Tsuji K; Komori T; Noda M
J Bone Miner Res; 2004 Sep; 19(9):1481-9. PubMed ID: 15312248
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
13. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
14. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency.
He J; Rosen CJ; Adams DJ; Kream BE
Bone; 2006 Jun; 38(6):826-35. PubMed ID: 16427371
[TBL] [Abstract][Full Text] [Related]
15. The Fos-related antigen Fra-1 is an activator of bone matrix formation.
Eferl R; Hoebertz A; Schilling AF; Rath M; Karreth F; Kenner L; Amling M; Wagner EF
EMBO J; 2004 Jul; 23(14):2789-99. PubMed ID: 15229648
[TBL] [Abstract][Full Text] [Related]
16. Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis.
Gordeladze JO; Noël D; Bony C; Apparailly F; Louis-Plence P; Jorgensen C
Exp Cell Res; 2008 Apr; 314(7):1495-506. PubMed ID: 18313048
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice.
Naganawa T; Xiao L; Abogunde E; Sobue T; Kalajzic I; Sabbieti M; Agas D; Hurley MM
Biochem Biophys Res Commun; 2006 Jan; 339(2):490-8. PubMed ID: 16298332
[TBL] [Abstract][Full Text] [Related]
18. [The regulation of hypoxia inducible factor-1alpha on osteoblast function in postmenopausal osteoporosis].
Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP; Clemens T
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1274-8. PubMed ID: 18067744
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
Silvestris F; Cafforio P; De Matteo M; Calvani N; Frassanito MA; Dammacco F
Clin Cancer Res; 2008 Oct; 14(19):6081-91. PubMed ID: 18829486
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts.
Bouvet-Gerbettaz S; Merigo E; Rocca JP; Carle GF; Rochet N
Lasers Surg Med; 2009 Apr; 41(4):291-7. PubMed ID: 19347941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
